Literature DB >> 28745637

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer.

Susan Kochall1, May-Linn Thepkaysone1, Sebastián A García1, Alexander M Betzler1, Jürgen Weitz2, Christoph Reissfelder1, Sebastian Schölch3.   

Abstract

Despite the advantages of easy applicability and cost-effectiveness, subcutaneous mouse models have severe limitations and do not accurately simulate tumor biology and tumor cell dissemination. Orthotopic mouse models have been introduced to overcome these limitations; however, such models are technically demanding, especially in hollow organs such as the large bowel. In order to produce uniform tumors which reliably grow and metastasize, standardized techniques of tumor cell preparation and injection are critical. We have developed an orthotopic mouse model of colorectal cancer (CRC) which develops highly uniform tumors and can be used for tumor biology studies as well as therapeutic trials. Tumor cells from either primary tumors, 2-dimensional (2D) cell lines or 3-dimensional (3D) organoids are injected into the cecum and, depending on the metastatic potential of the injected tumor cells, form highly metastatic tumors. In addition, CTCs can be found regularly. We here describe the technique of tumor cell preparation from both 2D cell lines and 3D organoids as well as primary tumor tissue, the surgical and injection techniques as well as the isolation of CTCs from the tumor-bearing mice, and present tips for troubleshooting.

Entities:  

Mesh:

Year:  2017        PMID: 28745637      PMCID: PMC5612534          DOI: 10.3791/55357

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  29 in total

Review 1.  Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.

Authors:  Jatin Roper; Kenneth E Hung
Journal:  Trends Pharmacol Sci       Date:  2012-06-26       Impact factor: 14.819

Review 2.  The mighty mouse: genetically engineered mouse models in cancer drug development.

Authors:  Norman E Sharpless; Ronald A Depinho
Journal:  Nat Rev Drug Discov       Date:  2006-08-18       Impact factor: 84.694

3.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

Review 4.  Prognostic relevance of minimal residual disease in colorectal cancer.

Authors:  Ulrich Bork; Robert Grützmann; Nuh N Rahbari; Sebastian Schölch; Marius Distler; Christoph Reissfelder; Moritz Koch; Jürgen Weitz
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Generation of a transgenic mouse for colorectal cancer research with intestinal cre expression limited to the large intestine.

Authors:  Yingben Xue; Robert Johnson; Marsha Desmet; Paul W Snyder; James C Fleet
Journal:  Mol Cancer Res       Date:  2010-07-27       Impact factor: 5.852

6.  Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer.

Authors:  Jatin Roper; Mark J Sinnamon; Erin M Coffee; Peter Belmont; Lily Keung; Larissa Georgeon-Richard; Wei Vivian Wang; Anthony C Faber; Jihye Yun; Ömer H Yilmaz; Roderick T Bronson; Eric S Martin; Philip N Tsichlis; Kenneth E Hung
Journal:  Cancer Lett       Date:  2014-02-24       Impact factor: 8.679

7.  An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research.

Authors:  Fa Wang; Robert L Johnson; Paul W Snyder; Marsha L DeSmet; James C Fleet
Journal:  Dig Dis Sci       Date:  2015-12-02       Impact factor: 3.199

8.  Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again?

Authors:  Nuh N Rahbari; Ulrich Bork; Sebastian Schölch; Christoph Reissfelder; Kristian Thorlund; Alexander Betzler; Christoph Kahlert; Martin Schneider; Alexis B Ulrich; Markus W Büchler; Jürgen Weitz; Moritz Koch
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

9.  A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains.

Authors:  Michelle M Simon; Simon Greenaway; Jacqueline K White; Helmut Fuchs; Valérie Gailus-Durner; Sara Wells; Tania Sorg; Kim Wong; Elodie Bedu; Elizabeth J Cartwright; Romain Dacquin; Sophia Djebali; Jeanne Estabel; Jochen Graw; Neil J Ingham; Ian J Jackson; Andreas Lengeling; Silvia Mandillo; Jacqueline Marvel; Hamid Meziane; Frédéric Preitner; Oliver Puk; Michel Roux; David J Adams; Sarah Atkins; Abdel Ayadi; Lore Becker; Andrew Blake; Debra Brooker; Heather Cater; Marie-France Champy; Roy Combe; Petr Danecek; Armida di Fenza; Hilary Gates; Anna-Karin Gerdin; Elisabetta Golini; John M Hancock; Wolfgang Hans; Sabine M Hölter; Tertius Hough; Pierre Jurdic; Thomas M Keane; Hugh Morgan; Werner Müller; Frauke Neff; George Nicholson; Bastian Pasche; Laura-Anne Roberson; Jan Rozman; Mark Sanderson; Luis Santos; Mohammed Selloum; Carl Shannon; Anne Southwell; Glauco P Tocchini-Valentini; Valerie E Vancollie; Henrik Westerberg; Wolfgang Wurst; Min Zi; Binnaz Yalcin; Ramiro Ramirez-Solis; Karen P Steel; Ann-Marie Mallon; Martin Hrabě de Angelis; Yann Herault; Steve D M Brown
Journal:  Genome Biol       Date:  2013-07-31       Impact factor: 13.583

10.  C57BL/6N Mice Are More Resistant to Ehrlich Ascites Tumors Than C57BL/6J Mice: The Role of Macrophage Nitric Oxide.

Authors:  Sergey Kalish; Svetlana Lyamina; Svetlana Chausova; Lada Kochetova; Yuri Malyshev; Eugenia Manukhina; Igor Malyshev
Journal:  Med Sci Monit Basic Res       Date:  2015-10-20
View more
  3 in total

1.  Albumin tailoring fluorescence and photothermal conversion effect of near-infrared-II fluorophore with aggregation-induced emission characteristics.

Authors:  Shuai Gao; Guoguang Wei; Sihang Zhang; Binbin Zheng; Jiaojiao Xu; Gaoxian Chen; Mingwang Li; Shaoli Song; Wei Fu; Zeyu Xiao; Wei Lu
Journal:  Nat Commun       Date:  2019-05-17       Impact factor: 14.919

Review 2.  Mouse models of colorectal cancer: Past, present and future perspectives.

Authors:  Florian Bürtin; Christina S Mullins; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

Review 3.  From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.

Authors:  Stephan Klöß; Susann Dehmel; Armin Braun; Michael J Parnham; Ulrike Köhl; Susanne Schiffmann
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.